​

Funding Round

Series B - ACELYRIN

Series B - ACELYRIN

Investment Firm

Overview

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Announced Date

Nov 16, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorRTW Investments
Participant InvestorDecheng Capital
Participant InvestorTybourne Capital Management
Participant InvestorvenBio Partners
Participant InvestorOrbiMed

Round Details and Background

ACELYRIN raised $250000000 on 2021-11-16 in Series B

ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 16, 2021
Series B - ACELYRIN
11-250.0M
Dec 15, 2020
Series A - ACELYRIN
1-8.0M
Sep 13, 2022
Series C - ACELYRIN
11-300.0M

Recent Activity

There is no recent news or activity for this profile.